PubMed Health⌕ Search

PubMed · 8583436

Thyroidectomy for large multinodular colloid goitre.

Abstract

Between 1983 and 1993 a total of 474 patients underwent thyroidectomy in one surgical unit. In 64 (14%) of these, a multinodular colloid goitre weighing more than 100 g was resected. Preoperative symptoms in this group of patients with large goitres included respiratory difficulty (42%) and dysphagia (22%) whilst 22% demonstrated distension of the veins of the neck or anterior chest wall. Plain radiography revealed evidence of tracheal deviation in 70% of patients and tracheal compression in 42%. Total thyroidectomy was carried out in 47 patients and unilateral total lobectomy in 11; six patients underwent completion thyroidectomy for massive recurrent goitre following previous resection. There was no perioperative mortality. Complications included permanent unilateral vocal cord paralysis in two patients (1.7% of recurrent laryngeal nerves at risk), permanent hypoparathyroidism in two (3.1%) and temporary emergency tracheostomy in one individual. We advocate total resection for patients with large multinodular colloid goitre.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

K R Gardiner, C F Russell. 1995. Thyroidectomy for large multinodular colloid goitre.. https://pubmed.ncbi.nlm.nih.gov/8583436/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

[The use for recombinant human TSH in patients with toxic and non-toxic nodular goiter].

Radioiodine ((131)I) treatment for multinodular toxic and non-toxic goiter is therapeutic procedure especially used in patients with contraindication for surgery. (131)I treatment diminishes the size of the goiter and treats hyperthyroidism. Sometimes, due to low radio-iodine uptake (RAIU), this procedure should not be used. In patients with goiter, the elimination of medication or substances rich in iodine is the first step to increase RAIU. Recombinant TSH (rhTSH) enhances RAIU in metastases distant from thyroid cancer. Studies were performed in recent years using rhTSH to increase the radio-iodine uptake in multinodular toxic and non-toxic goiter. These methods led to enhanced radio-iodine uptake, decreased the level of activity of the (131)I administered, changed the distribution of (131)I in the thyroid, lowered the absorption dose, and increased the number of patients with hypothyroidism. The uses of rhTSH can lead to exacerbation of the signs and symptoms of hyperthyroidism, so patients should be hospitalized. Until now there has been no evidence that the adverse effects outweigh the positive results of using rhTSH. The use of rhTSH in benign goiter disease is not yet approved, but its positive activity in multinodular goiter is very interesting and promising.

Goiter, Nodular↗